Lexaria Bioscience Corp Ordinary Shares LEXX 深 滬
等待開盤 07-18 09:30:00 美东时间
0.87
0.000
0.00%
華盛通- 最 高0.90
- 今 開0.8916
- 成交量 10.56万股
- 最 低 0.8425
- 昨 收 0.87
- 總市值 1701.65万
- 52周最高 4.38
- 市盈率 靜 --
- 換手率 0.54%
- 52周最低 0.7941
- 委 比 3.03%
- 總股本 1955.92万
- 歷史最高 12.50
- 量 比 0.71
- 振 幅 6.61%
- 歷史最低 0.6488
- 每 手 1
- 風險率 0.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lexaria Bioscience Q3 EPS $(0.21) Misses $(0.16) Estimate, Sales $174.000K Beat $91.333K Estimate
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 33.76 percent. This is a 61.54 percent decrease over losses of $(0.13) per share
07-15 06:32
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
HC Wainwright & Co. Maintains Buy on Lexaria Bioscience, Lowers Price Target to $5
HC Wainwright & Co. analyst Yi Chen maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and lowers the price target from $7 to $5.
07-01 19:40
Lexaria Bioscience Receives Two New Patents For Treatment Of Epilepsy And For Sublingual Delivery Of Nicotine
New patents received for the treatment of epilepsy and for the sublingual delivery of nicotineKELOWNA, BC / ACCESS Newswire / June 23, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or
06-23 21:18
Lexaria’s Oral Liraglutide Shows Promise in Reducing Adverse Events
Lexaria Bioscience ( ($LEXX) ) just unveiled an announcement. Lexaria Bioscienc...
06-11 22:39
Lexaria Advances Collaboration with Pharma Partner on Drug Delivery Technology
Lexaria Bioscience ( ($LEXX) ) just unveiled an update. Lexaria Bioscience Corp...
05-12 23:46
Lexaria Completes Enrollment for Pioneering Drug Delivery Study
An announcement from Lexaria Bioscience ( ($LEXX) ) is now available. Lexaria B...
04-03 23:08
Lexaria Updates Ongoing Human Study GLP-1-H24-4
Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss
04-03 21:16
Lexaria’s Oral Capsules Rival Injectable Weight Loss Treatment
Lexaria Bioscience ( ($LEXX) ) has provided an announcement. Lexaria Bioscience...
03-18 23:08
